Related Experiment Video
Updated: Jul 13, 2025
06:15
Quantification of Efferocytosis by Single-cell Fluorescence Microscopy
Published on: August 18, 2018
12.7K
Efferocytosis and Respiratory Disease
Wenxue Zheng1, Zhengjie Zhou1, Xiaoping Guo1
1The Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
International Journal of Molecular Sciences
|October 14, 2023
Summary
Cellular waste removal, known as efferocytosis, is vital for health. Dysfunctional efferocytosis is linked to respiratory diseases, highlighting its therapeutic potential.
Area of Science:
- Cell Biology
- Immunology
- Pathology
Background:
- Living organisms rely on cellular processes like proliferation, differentiation, senescence, and death.
- Efficient removal of dead cells (efferocytosis) is crucial for maintaining organismal homeostasis and health.
- Failure in efferocytosis can lead to various diseases, with growing evidence linking it to respiratory pathologies.
Purpose of the Study:
- To review the mechanisms and regulation of macrophage-mediated efferocytosis.
- To explore the role of efferocytosis in diverse lung diseases.
- To discuss therapeutic strategies targeting efferocytosis for lung disease treatment.
Main Methods:
- Literature review focusing on efferocytosis mechanisms and regulation.
- Analysis of the involvement of efferocytosis in different lung diseases.
- Summary of clinical drugs affecting efferocytosis.
Main Results:
- Efferocytosis is a key process for cellular homeostasis.
- Impaired efferocytosis is implicated in the pathogenesis of respiratory diseases.
- Modulating efferocytosis presents potential therapeutic avenues for lung conditions.
Conclusions:
- Understanding efferocytosis is critical for respiratory disease research.
- Targeting efferocytosis offers novel treatment strategies for lung diseases.
- Clinical drugs impacting efferocytosis warrant further investigation for therapeutic application.
Related Concept Videos
01:24External and Internal Respiration
4.0K
External respiration occurs in the lungs, and it is the first step in the journey of oxygen inside the body. When we inhale, oxygen enters our lungs and diffuses across the thin alveolar membrane. The alveoli are tiny, air-filled sacs that provide a vast surface area for gas exchange. Oxygen in the alveoli has a higher partial pressure (105 mmHg) than in the adjacent pulmonary capillaries (40 mmHg), establishing a pressure gradient. As a result, oxygen molecules move from the alveoli into the...
4.0K
01:05Breathing
59.5K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
59.5K
01:21Acute Respiratory Failure-II
250
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
250
01:29Acute Respiratory Failure-V
144
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
144
01:30Acute Respiratory Failure-III
192
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
192
01:31Common Respiratory Disorders
602
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
602